Search the Newsreel

Price to earnings forward of Astron Paper & Board Mill Ltd. – NSE:ASTRON

Enterprise value to revenue forward of Astron Paper & Board Mill Ltd. – NSE:ASTRON

Short Interest in AstroNova, Inc. (NASDAQ:ALOT) Expands By 119.1%

Short interest in AstroNova, Inc. (NASDAQ:ALOT) significantly increased by 119.1% in July, reaching 49,242 shares, which represents 0.7% of its outstanding shares. Despite institutional investors like BlackRock and Walleye Capital establishing new positions, and the company beating analyst estimates with quarterly EPS of $0.19 …

Sutro Biopharma, Inc. (NASDAQ:STRO) Just Reported And Analysts Have Been Lifting Their Price Targets

How (HASI) Movements Inform Risk Allocation Models

This article analyzes Hannon Armstrong Sustainable Infrastructure Capital Inc. (NASDAQ: HASI) using AI models, indicating strong sentiment across all horizons and an exceptional 25.3:1 risk-reward setup. It outlines specific institutional trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) with entry, target, and stop-loss …

Armstrong World Industries, Inc. (NYSE:AWI) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Armstrong World Industries, Inc. (NYSE:AWI) has received a consensus "Moderate Buy" rating from analysts, with an average 12-month price target of $213. The company recently surpassed quarterly expectations with $2.36 EPS and $472 million in revenue, an 11.2% year-over-year increase. Additionally, Armstrong reaffirmed its …

Sutro Biopharma (STRO): Perceptive Advisors reports 7.9% beneficial stake

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have reported a beneficial ownership of 7.9% of Sutro Biopharma's common stock, totaling 1,304,846 shares. This ownership is based on 16,572,171 shares outstanding as of August 7, 2026. The reporting persons have …

Sutro Biopharma (STRO): Point72 group reports 1.4% stake in 13G/A

Point72 Asset Management, along with Point72 Capital Advisors, Inc. and Steven A. Cohen, has filed an amended SCHEDULE 13G/A, reporting a 1.4% beneficial ownership stake in Sutro Biopharma (STRO). This represents 237,827 shares of common stock as of June 30, 2026, with shared voting …

American Century group reports 4.5% stake in Astronics Corporation (ATRO)

American Century Investment Management, Inc., along with American Century Companies, Inc. and the Stowers Institute for Medical Research, have collectively reported a passive ownership of 4.5% in Astronics Corporation (ATRO) common stock. This stake, amounting to 1,436,706 shares as of June 30, 2026, grants …

Sutro Biopharma Q3 EPS Forecast Reduced by HC Wainwright

Handelsbanken Fonder AB Grows Stock Position in Smurfit Westrock PLC $SW

Handelsbanken Fonder AB increased its stake in Smurfit Westrock PLC by 23.4% in the second quarter, bringing its holdings to 194,600 shares valued at approximately $9 million. The company reported quarterly revenue of $8.03 billion, exceeding estimates, but missed EPS expectations. Smurfit Westrock also …

Astronics (ATRO) Stock Price Nears Perfection After Margin Breakthrough

Astronics Corporation stock hits all-time high at 92.78 USD

Astronics Corporation stock reached an all-time high of $92.78, reflecting a 208% increase over the past year and 94% year-to-date growth. This performance is supported by strong Q2 results, where the company surpassed analyst expectations for earnings and revenue, and subsequently raised its fiscal …

Smurfit Westrock PLC stock outperforms competitors on strong trading day

Shares of Smurfit Westrock PLC (SW) rose 1.56% to $50.02 on Thursday, outperforming the broader market which also saw gains in the S&P 500 Index and Dow Jones Industrial Average. The company's stock closed 5.00% below its 52-week high of $52.65.

Sutro Biopharma (NASDAQ:STRO) Earns Outperform Rating from Wedbush

Wedbush has reiterated an "outperform" rating for Sutro Biopharma (NASDAQ:STRO) with a $60 price target, suggesting a significant upside. This comes despite the company missing its Q2 earnings and revenue estimates. Several other analysts also hold "Buy" or "Outperform" ratings for the stock, with …

Are Wall Street Analysts Bullish on Smurfit Westrock Stock?

Smurfit Westrock Plc (SW) has underperformed the S&P 500 over the past year but has outperformed in 2026. Despite missing Q2 2026 earnings expectations due to higher fuel and shipping costs, analysts maintain a "Strong Buy" consensus for SW stock, with a mean price …

Eastroc Beverage Sets Interim Dividend and Key Dates for 2026 Payout

Eastroc Beverage Calls August EGM on Payout Plans and H-Share Buyback Mandate

Trinity Street Asset Management LLP Acquires Shares of 5,261,555 Smurfit Westrock PLC $SW

Trinity Street Asset Management LLP has acquired a new stake of 5,261,555 shares in Smurfit Westrock PLC (NYSE:SW), valued at approximately $243.4 million, making it their third-largest holding. This investment gives Trinity Street Asset Management LLP a 1% stake in the company, which sees …

Citizens cuts Sutro Biopharma stock price target on revenue miss

Can Astronics (ATRO) Justify A Premium Price On Cash Flow And Earnings?

Smurfit Westrock PLC (NYSE:SW) Given Average Rating of "Moderate Buy" by Analysts

Smurfit Westrock PLC (NYSE:SW) has received an average rating of "Moderate Buy" from analysts, with a consensus 12-month price target of $57.62, significantly above its current share price of $49.21. The company reported mixed results in its latest quarter, with revenue exceeding estimates but …

How Smurfit Westrock’s US$100 Price Hike for Containerboard Will Impact Smurfit Westrock (SW) Investors

Is Sutro Biopharma Inc (STRO) Facing Pressures After Q2 Earnings

SUTRO BIOPHARMA, INC. 2Q 2026: Revenue $9.84M, EPS ($2.33) — 10-Q Summary

Sutro Biopharma (STRO) reported second-quarter 2026 results with a significant revenue decline to $9.84M and a widened GAAP net loss of $38.53M, or $2.33 diluted EPS, primarily due to the derecognition of revenue from Ipsen. Despite the financial downturn, the company made clinical progress …

Smurfit Westrock (SW): Capital Research Global Investors reports 8.1% stake

Capital Research Global Investors has reported an 8.1% beneficial ownership stake in Smurfit Westrock plc (SW), according to a recent Schedule 13G/A SEC filing. This position amounts to 42,655,360 shares out of an estimated 524,514,988 outstanding shares as of June 30, 2026. The filing …

Astronics Corporation (NASDAQ: ATRO) lifts profit on 2026 aerospace demand

Astronics Corporation (NASDAQ: ATRO) reported substantially stronger financial results for the quarter and six months ended July 4, 2026, driven by significant growth in its Aerospace segment and a return to profitability for its Test Systems segment. Six-month sales increased to $490.6 million from …

Astronics Corp 2026: Revenue $259.96M, EPS $0.75— 10-Q Summary

Astronics Corp (ATRO) reported strong financial results for the 2026 quarter, with revenue reaching $259.96 million and diluted EPS of $0.75. This performance represents significant year-over-year growth, primarily driven by increased demand in Aerospace and a recovery in Test Systems. The company also highlighted …

Astronics (ATRO) Stock Surges After Blowout Q2 Earnings Beat

Astronics Corporation (ATRO) experienced a significant stock surge after reporting blowout Q2 2026 earnings, driven by record sales of $260M and an EPS jump to $0.75. The company exceeded analyst expectations for both revenue and earnings, raised its full-year guidance, and saw record bookings …

Why is Sutro Biopharma Stock Falling On Wednesday?

Sutro Biopharma (NASDAQ: STRO) stock is falling due to challenges following an update on its STRO-004 Phase 1 study, despite reporting early clinical activity. The company noted dose-limiting toxicities only at the highest dose, leading to dose reduction. Analysts generally have a "Buy" rating …

HA Sustainable Infrastructure Capital (HASI) Is Up 5.6% After Raising 2028 EPS Outlook And Dividend

Why Astronics Stock Popped Today

Key Points Astronics beat on both sales and earnings last night. Management is promising positive free cash flow for the year -- and is probably right about that.10 stocks we like better than Astronics › Aerospace and defense company Astronics Corporation (NASDAQ: ATRO) stock …

Astronics Stock (ATRO) Surges 15% on Backlog Hitting 76% of Fresh Revenue Goal

Astronics (ATRO) stock surged 15.3% after the company reported a record backlog of $780.6 million, representing 75.8% of its updated revenue guidance midpoint. The company saw a 27% increase in sales and a 102.9% jump in adjusted EBITDA in the second quarter, leading to …